HEADER ANTIMICROBIAL PROTEIN 16-JAN-06 2DCV TITLE THE SOLUTION STRUCTURE OF HORSESHOE CRAB ANTIMICROBIAL TITLE 2 PEPTIDE TACHYSTATIN B WITH THE INHIBITORY CYSTINE-KNOT TITLE 3 MOTIF COMPND MOL_ID: 1; COMPND 2 MOLECULE: TACHYSTATIN-B1; COMPND 3 CHAIN: A SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TACHYPLEUS TRIDENTATUS; SOURCE 3 ORGANISM_TAXID: 6853; SOURCE 4 CELL: HEMOCYTE KEYWDS ANTIMICROBIAL, CYSTINE-KNOT, ANTIMICROBIAL PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR N.FUJITANI,T.KOHNO REVDAT 3 24-FEB-09 2DCV 1 VERSN REVDAT 2 17-APR-07 2DCV 1 JRNL REVDAT 1 23-JAN-07 2DCV 0 JRNL AUTH N.FUJITANI,T.KOUNO,T.NAKAHARA,K.TAKAYA,T.OSAKI, JRNL AUTH 2 S.KAWABATA,M.MIZUGUCHI,T.AIZAWA,M.DEMURA, JRNL AUTH 3 S.NISHIMURA,K.KAWANO JRNL TITL THE SOLUTION STRUCTURE OF HORSESHOE CRAB JRNL TITL 2 ANTIMICROBIAL PEPTIDE TACHYSTATIN B WITH AN JRNL TITL 3 INHIBITORY CYSTINE-KNOT MOTIF JRNL REF J.PEPT.SCI. V. 13 269 2007 JRNL REFN ISSN 1075-2617 JRNL PMID 17394123 JRNL DOI 10.1002/PSC.846 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH T.OSAKI,M.OMOTEZAKO,R.NAGAYAMA,M.HIRATA,S.IWANAGA, REMARK 1 AUTH 2 J.KASAHARA,J.HATTORI,I.ITO,H.SUGIYAMA,S.KAWABATA REMARK 1 TITL HORSESHOE CRAB HEMOCYTE-DERIVED ANTIMICROBIAL REMARK 1 TITL 2 POLYPEPTIDES, TACHYSTATINS, WITH SEQUENCE REMARK 1 TITL 3 SIMILARITY TO SPIDER NEUROTOXINS REMARK 1 REF J.BIOL.CHEM. V. 274 26172 1999 REMARK 1 REFN ISSN 0021-9258 REMARK 1 PMID 10473569 REMARK 1 DOI 10.1074/JBC.274.37.26172 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU,READ, REMARK 3 RICE,SIMONSON,WARREN REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2DCV COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 18-JAN-06. REMARK 100 THE RCSB ID CODE IS RCSB025264. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 3.5 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.73MM TACHYSTATIN B; 90% REMARK 210 H2O, 10% D2O; PH 3.5 REMARK 210 UNBUFFERED; 0.73MM TACHYSTATIN REMARK 210 B; 100% D2O; PH 3.5 UNBUFFERED REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : DQF-COSY, 2D TOCSY, 2D NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ, 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CNS 1.1, NMRPIPE 2.3 REMARK 210 METHOD USED : DISTANCE GEOMETRY, SIMULATED REMARK 210 ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 SER A 15 -173.36 -68.70 REMARK 500 1 CYS A 20 175.71 -59.88 REMARK 500 1 PRO A 30 92.36 -50.00 REMARK 500 2 SER A 3 -79.67 -174.92 REMARK 500 2 CYS A 19 -176.14 -69.93 REMARK 500 2 CYS A 20 178.56 -59.04 REMARK 500 2 PRO A 30 96.13 -54.93 REMARK 500 3 SER A 15 -170.37 -64.92 REMARK 500 3 PRO A 30 91.28 -50.74 REMARK 500 4 PRO A 30 98.94 -51.80 REMARK 500 5 VAL A 2 30.98 -99.83 REMARK 500 5 SER A 15 -177.92 -67.45 REMARK 500 5 CYS A 20 170.73 -59.64 REMARK 500 5 PRO A 30 95.31 -49.60 REMARK 500 6 PRO A 30 99.59 -49.86 REMARK 500 6 ASN A 41 35.28 -141.28 REMARK 500 7 SER A 15 -179.50 -62.24 REMARK 500 7 CYS A 19 -176.75 -69.98 REMARK 500 7 ASP A 28 -72.39 -75.01 REMARK 500 7 PRO A 30 103.77 -52.21 REMARK 500 8 PRO A 30 99.73 -47.79 REMARK 500 8 ASN A 41 84.75 -159.44 REMARK 500 9 SER A 15 -179.92 -59.45 REMARK 500 9 PRO A 30 92.73 -50.29 REMARK 500 10 SER A 15 -175.93 -69.47 REMARK 500 10 CYS A 19 -178.91 -69.95 REMARK 500 10 PRO A 30 92.52 -50.49 REMARK 500 11 PRO A 30 90.52 -51.90 REMARK 500 12 PRO A 30 96.87 -48.79 REMARK 500 12 ARG A 40 80.45 -69.54 REMARK 500 13 SER A 18 -177.10 -69.98 REMARK 500 13 CYS A 19 -176.74 -69.88 REMARK 500 13 PRO A 30 92.05 -52.07 REMARK 500 14 VAL A 2 -66.52 -101.46 REMARK 500 14 CYS A 19 -178.74 -69.90 REMARK 500 14 PRO A 30 99.49 -52.55 REMARK 500 14 ASN A 41 106.21 -164.29 REMARK 500 15 SER A 15 -179.92 -57.70 REMARK 500 15 PRO A 30 100.90 -49.24 REMARK 500 16 VAL A 2 30.50 -98.62 REMARK 500 16 ARG A 17 172.94 -55.94 REMARK 500 16 PRO A 30 96.37 -50.64 REMARK 500 17 SER A 15 174.85 -59.71 REMARK 500 17 PRO A 30 99.93 -48.51 REMARK 500 17 ARG A 40 46.99 -95.10 REMARK 500 18 PRO A 30 99.99 -47.78 REMARK 500 18 ASN A 41 32.23 -99.06 REMARK 500 19 VAL A 2 31.12 -98.57 REMARK 500 19 SER A 18 -178.86 -69.99 REMARK 500 19 PRO A 30 97.39 -49.01 REMARK 500 20 CYS A 19 -178.77 -69.94 REMARK 500 20 PRO A 30 92.12 -50.67 REMARK 500 20 ARG A 40 44.29 -93.35 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2DCW RELATED DB: PDB REMARK 900 ISOPEPTIDE OF THIS PROTEIN DBREF 2DCV A 1 42 UNP P0C1Z8 TACB1_TACTR 1 42 SEQRES 1 A 42 TYR VAL SER CYS LEU PHE ARG GLY ALA ARG CYS ARG VAL SEQRES 2 A 42 TYR SER GLY ARG SER CYS CYS PHE GLY TYR TYR CYS ARG SEQRES 3 A 42 ARG ASP PHE PRO GLY SER ILE PHE GLY THR CYS SER ARG SEQRES 4 A 42 ARG ASN PHE SHEET 1 A 3 ARG A 10 ARG A 12 0 SHEET 2 A 3 PHE A 34 ARG A 39 -1 O GLY A 35 N CYS A 11 SHEET 3 A 3 TYR A 23 ARG A 27 -1 N ARG A 26 O THR A 36 SSBOND 1 CYS A 4 CYS A 20 1555 1555 2.03 SSBOND 2 CYS A 11 CYS A 25 1555 1555 2.03 SSBOND 3 CYS A 19 CYS A 37 1555 1555 2.03 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL MASTER 136 0 0 0 3 0 0 6 0 0 0 4 END